Search - tctmd.com

Displaying 461 - 480 of 662

Sort: Relevancy | Date

Presentation

Case Presentation: 62 yo Woman With Severe AS and MS, NYHA class IV

Presenter: Mike Dyal

October 30, 2015

Presentation

High Risk PCI With Hemodynamic Support 'Protected PCI'

Presenter: Mauricio G. Cohen

October 30, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Conference News TCT 2015

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

October 14, 2015

News Industry News

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

October 14, 2015

News Conference News TCT 2015

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

October 13, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Daily News

在人工动脉瓣中二尖瓣运动降低并不少见，但可通过抗凝予以治疗

L.A. McKeown

October 08, 2015

News Daily News

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

L.A. McKeown

October 08, 2015

News Daily News

El Menor Movimiento de las Valvas en las Válvulas Aórticas Bioprotésicas es Habitual Pero puede Remediarse con el Uso de Anticoagulación

L.A. McKeown

October 08, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Industry News

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

October 07, 2015

Presentation

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves

Presenter: Raj R. Makkar

October 06, 2015

News Industry News

Occlutech obtains European CE Approval for its novel mVSD Device

September 30, 2015

News Daily News

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

September 22, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

Presentation

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Presenter: Marco Barbanti

September 21, 2015

Advertisement

Case Presentation: 62 yo Woman With Severe AS and MS, NYHA class IV

High Risk PCI With Hemodynamic Support 'Protected PCI'

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

MISTRAL-C: Cerebral Protection in TAVR May Reduce New Lesions

First US Multi-center Study Finds Unprotected TAVR Procedures Produce New Brain Lesions in Nearly All Cases

Darbepoetin Plus Iron Fails to Reduce Transfusion Rates After TAVR in Anemia Patients

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

在人工动脉瓣中二尖瓣运动降低并不少见，但可通过抗凝予以治疗

Reduced Leaflet Motion in Bioprosthetic Aortic Valves Not Uncommon But Remedied by Anticoagulation

El Menor Movimiento de las Valvas en las Válvulas Aórticas Bioprotésicas es Habitual Pero puede Remediarse con el Uso de Anticoagulación

Boston Scientific Announces Scheduled Presentations At TCT 2015

Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015

Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves

Occlutech obtains European CE Approval for its novel mVSD Device

RenalGuard 防止 TAVR 患者发生 AKI 的效果优于生理盐水

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

PROTECT-TAVI: AKI With the RenalGuard System in Patients Undergoing TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content